BaiyaPhytopharm Announces Preliminary Results of the Phase 1 Clinical Trial of its COVID-19 Vaccine Baiya SARS-CoV-2 Vax 2
Study Design The ongoing phase 1 trial is a dose-escalating open-label study to evaluate the Baiya SARS-CoV-2 Vax2 vaccine in…

August 25, 2022